Olanzapine
For Laboratory Research Only. Not for Clinical or Personal Use.
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Olanzapine
Description:
Olanzapine (LY170053) is a selective, orally active monoaminergic antagonist with high affinity binding to serotonin H1, 5HT2A/2C, 5HT3, 5HT6 (Ki=7, 4, 11, 57, and 5 nM, respectively), dopamine D1-4 (Ki=11 to 31 nM), muscarinic M1-5 (Ki=1.9-25 nM), and adrenergic α1 receptor (Ki=19 nM) . Olanzapine is an atypical antipsychotic[1][2].Product Name Alternative:
LY170053UNSPSC:
12352005Hazard Statement:
H302, H315, H319, H335Target:
5-HT Receptor; Adrenergic Receptor; Apoptosis; Autophagy; Dopamine Receptor; mAChR; MitophagyType:
Reference compoundRelated Pathways:
Apoptosis; Autophagy; GPCR/G Protein; Neuronal SignalingApplications:
Cancer-programmed cell deathField of Research:
Neurological Disease; CancerAssay Protocol:
https://www.medchemexpress.com/Olanzapine.htmlConcentration:
10mMPurity:
99.96Solubility:
DMSO : 20 mg/mL (ultrasonic)Smiles:
CC1=CC(C(N2CCN(C)CC2)=N3)=C(S1)NC4=C3C=CC=C4Molecular Formula:
C17H20N4SMolecular Weight:
312.44Precautions:
H302, H315, H319, H335References & Citations:
[1]APPROVED AGREED-UPON LABELING.|[2]Olanzapine for Injection, powder, for solution for intramuscular use.|[3]Vucicevic L, et al. Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine. Autophagy. 2014;10 (12) :2362-78.|[4]Karpel-Massler G, et al. Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide's antiproliferative effect. J Neurooncol. 2015 Mar;122 (1) :21-33.|[5]Coccurello R, et al. Chronic administration of olanzapine induces metabolic and food intake alterations: a mousemodel of the atypical antipsychotic-associated adverse effects. Psychopharmacology (Berl) . 2006 Jul;186 (4) :561-71.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, protect from light)Scientific Category:
Reference compound1Clinical Information:
LaunchedIsoform:
5-HT2 Receptor;5-HT6 Receptor; Dopamine Receptor; lactoferrin; mLAG-3; MUC2; α-1 microglobulinCAS Number:
[132539-06-1]
